WithdrawnPhase 2ketamine

ED Treatment of Suicidal Patients With Ketamine Infusion

Sponsored by University of California, Davis

NCT ID
NCT03502551
0
Start Date
2019-04-01
Est. Completion
2019-06-30

About This Study

This study aims to determine if a single intravenous (IV) dose of ketamine given in the emergency department (ED) can provide a long term reduction in suicidal ideation, lower time to ED discharge, and increase discharge to home or voluntary treatment facilities all while being safe.

Conditions Studied

SuicideSuicidal Ideation

Interventions

  • •Ketamine

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Age ≥ 18 years
* Chief complaint of suicidal thoughts with a MADRS-SI score \> 3
* Major depressive episode with MADRS \> 19 (moderate to severe)

Exclusion Criteria:

* Pregnancy
* Psychosis
* Acute intoxication with alcohol or illicit drugs
* Acute withdrawal from alcohol or illicit drugs
* Adults otherwise unable to consent
* Concurrent, active medical illness requiring medical hospitalization
* Inability to follow-up including no permanent address or valid telephone number
* Patients unable to attend outpatient follow-up (no medical insurance, refusal to follow-up, no established care provider)
* Specific contraindication to the use of ketamine (concern for increased intracranial or intraocular pressure, known allergy to ketamine)
* Greater than 12 hours from time of ED presentation
* Prisoners

Study Locations (1)

University of California Davis Medical Center
Sacramento, California, United States

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

ED Treatment of Suicidal Patients With Ketamine Infusion | Huxley